Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies

by Terry A. Jacot, Meredith R. Clark, Oluwatosin E. Adedipe, Susan Godbout, Abby G. Peele, Susan Ju, Jill L. Schwartz, Andrea R. Thurman, Gustavo F. Doncel
Published 2018-11-01

Application of a composite measure of product adherence, protocol compliance, and semen exposure to a phase III microbicide HIV prevention trial

by Terry A. Jacot, Meredith R. Clark, Oluwatosin E. Adedipe, Susan Godbout, Tina Cunningham, Susan Ju, Jill L. Schwartz, Sinead Delany-Moretlwe, Andrea R. Thurman, Gustavo F. Doncel
Published 2021-09-01

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled...

by Andrea R. Thurman, MD, Jill L. Schwartz, MD, Mackenzie L. Cottrell, PharmD, Vivian Brache, Lic, Beatrice A. Chen, MD, MPH, Leila Cochón, Lic, Susan Ju, BA, Ian McGowan, MD PhD, James F. Rooney, MD, Scott McCallister, MD, Gustavo F. Doncel, MD PhD
Published 2021-06-01